Evidence map›Paper›PMID 40872756›Full record

ArticleViruses2025

CRISPR/Cas9-Driven Engineering of AcMNPV Using Dual gRNA for Optimized Recombinant Protein Production.

Rocco Valente, Joaquín Poodts, Joaquín Manuel Birenbaum, María Sol Rodriguez, Ignacio Smith, Jorge Alejandro Simonin, Franco Uriel Cuccovia Warlet, Aldana Trabucchi, Salvador Herrero, María Victoria Miranda and 2 more

Abstract read
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rocco ValenteCátedra de Biotecnología, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina.
Joaquín PoodtsCátedra de Biotecnología, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina.
Joaquín Manuel BirenbaumCátedra de Biotecnología, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina.ORCID 0000-0001-9044-8762
María Sol RodriguezCátedra de Biotecnología, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina.
Ignacio SmithCátedra de Biotecnología, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina.
Jorge Alejandro SimoninLaboratorio de Ingeniería Genética y Biología Celular y Molecular, Área Virosis de Insectos, Instituto de Microbiología Básica y Aplicada, Comisión de Investigaciones Científicas de la Provincia de Buenos Aires, Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Roque Sáenz Peña 352, Bernal, Buenos Aires B1876BXD, Argentina.ORCID 0000-0003-2707-5478
Franco Uriel Cuccovia WarletLaboratorio de Ingeniería Genética y Biología Celular y Molecular, Área Virosis de Insectos, Instituto de Microbiología Básica y Aplicada, Comisión de Investigaciones Científicas de la Provincia de Buenos Aires, Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Roque Sáenz Peña 352, Bernal, Buenos Aires B1876BXD, Argentina.
Aldana TrabucchiCátedra de Inmunología, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina.
Salvador HerreroDepartment of Genetics and University, Institute of Biotechnology and Biomedicine (BIOTECMED), Universitat de València, Dr. Moliner 50, Burjassot, 46100 Valencia, Spain.
María Victoria MirandaCátedra de Biotecnología, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina.ORCID 0000-0003-0862-2122
Mariano Nicolás BelaichLaboratorio de Ingeniería Genética y Biología Celular y Molecular, Área Virosis de Insectos, Instituto de Microbiología Básica y Aplicada, Comisión de Investigaciones Científicas de la Provincia de Buenos Aires, Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Roque Sáenz Peña 352, Bernal, Buenos Aires B1876BXD, Argentina.ORCID 0000-0002-3346-4587
Alexandra Marisa TargovnikCátedra de Biotecnología, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina.ORCID 0000-0003-4480-031X

Funding

Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT-2021-00144Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT-2021-I-A-00824Consejo Nacional de Investigaciones Científicas y Técnicas PIP 2021-1657University of Buenos Aires UBACyT 20020190100285BA
6 · The paper itself

Abstract

The CRISPR/Cas9 system is a powerful genome-editing tool that is applied in baculovirus engineering. In this study, we present the first report of the AcMNPV genome deletions for bioproduction purposes, using a dual single-guide RNA (sgRNA) CRISPR/Cas9 approach. We used this method to remove nonessential genes for the budded virus and boost recombinant protein yields when applied as BEVS. We show that the co-delivery of two distinct ribonucleoprotein (RNP) complexes, each assembled with a sgRNA and Cas9, into Sf9 insect cells efficiently generated deletions of fragments containing tandem genes in the genome. To evaluate the potential of this method, we assessed the expression of two model proteins, eGFP and HRPc, in insect cells and larvae. The gene deletions had diverse effects on protein expression: some significantly enhanced it while others reduced production. These results indicate that, although the targeted genes are nonessential, their removal can differentially affect recombinant protein yields depending on the host. Notably, HRPC expression increased up to 3.1-fold in

Indexed as

CRISPR-Cas SystemsNucleopolyhedrovirusesRecombinant ProteinsRNA, Guide, CRISPR-Cas SystemsAnimalsGene DeletionGene EditingGenetic EngineeringGenome, ViralGreen Fluorescent ProteinsLarvaSf9 CellsSpodopteraGreen Fluorescent ProteinsRecombinant ProteinsRNA, Guide, CRISPR-Cas SystemsAcMNPVbaculovirusCRISPR/Cas9dual sgRNAexpressiongenome editingknockoutoptimizationRachiplusia nuSf9 cellsSpodoptera frugiperda

Identifiers

PMID40872756
PMCPMC12390737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.